The current SNGX market cap is 6.21M. The company's latest EPS is USD -1.3295 and P/E is -0.46.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 166k | 366k | 257k | 207k | 131k |
Operating Income | -3.08M | -3.57M | -2.15M | -1.63M | -1.78M |
Net Income | -3.31M | -3.75M | -1.05M | -1.61M | -1.66M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 5.24M | 4.63M | 2.36M | 824k | 949k |
Operating Income | -9.06M | -10.54M | -18.59M | -13.14M | -14.24M |
Net Income | -8.9M | -9.36M | -17.69M | -12.55M | -13.8M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 17.95M | 14.28M | 11.1M | 13.83M | 11.3M |
Total Liabilities | 16.92M | 16.75M | 14.49M | 8.03M | 7.08M |
Total Equity | 1.03M | -2.47M | -3.39M | 5.8M | 4.22M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 10.49M | 7.78M | 19.89M | 26.87M | 14.28M |
Total Liabilities | 4.21M | 6.32M | 16.15M | 16.15M | 16.75M |
Total Equity | 6.28M | 1.46M | 3.74M | 10.72M | -2.47M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -9.02M | -12.65M | -2.17M | -4.09M | -6.78M |
Investing | -13k | -13k | N/A | N/A | N/A |
Financing | N/A | 77k | -932k | 3.88M | 3.71M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -7.24M | -7.51M | -11.46M | -11.74M | -12.65M |
Investing | -1,000 | -24k | -7k | -12k | -13k |
Financing | 8.42M | 4.01M | 24.68M | 19.06M | 77k |
Market Cap | 6.21M |
Price to Earnings Ratio | -0.46 |
Price to Sales Ratio | 6.67 |
Price to Cash Ratio | 0.47 |
Price to Book Ratio | -2.56 |
Dividend Yield | - |
Shares Outstanding | 10.38M |
Average Volume (1 week) | 61.65k |
Average Volume (1 Month) | 106.46k |
52 Week Change | -68.19% |
52 Week High | 4.20 |
52 Week Low | 0.38 |
Spread (Intraday) | 0.01 (1.64%) |
Company Name | Soligenix Inc |
Address |
3411 silverside road tatnall wilmington, delaware 19810 |
Website | https://www.soligenix.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.